DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/72w563/global_cervical) has announced the addition of the "Global Cervical Cancer Market 2015-2019" report to their offering.
The report forecasts the global cervical cancer market to grow at a CAGR of 4.87% over the period 2014-2019.
The report covers the current scenario and the growth prospects of the global cervical cancer market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used in the treatment and prevention of cervical cancer.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cervical cancer market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview
PART 06: Market landscape
PART 07: Market segmentation by application
PART 08: Market segmentation by type of therapy
PART 09: Geographical segmentation
PART 10: Key brand analysis
PART 11: Pipeline portfolio
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Key vendor analysis
Companies Mentioned:
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Merck
- Advaxis Immunotherapies
- Bionor Pharma
- Dendreon Corporation
- Inovio Pharmaceuticals
- ISA Pharmaceuticals
- Otsuka Pharmaceuticals
- Profectus Biosciences
- Virometix
-
Zeria Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/72w563/global_cervical
